The use of herbal alternative medicines in neuropsychiatry: A report of the ANPA Committee on Research

W. Curt LaFrance; Edward C. Lauterbach; C. Edward Coffey; Stephen P. Salloway; Daniel I. Kaufer; Alison Reeve; Donald R. Royall; Elizabeth Aylward; Teresa A. Rummans; Mark R. Lovell

doi:10.1176/jnp.12.2.177

The use of herbal alternative medicines in neuropsychiatry: A report of the ANPA Committee on Research

W. Curt LaFrance, Edward C. Lauterbach, C. Edward Coffey, Stephen P. Salloway, Daniel I. Kaufer, Alison Reeve, Donald R. Royall, Elizabeth Aylward, Teresa A. Rummans, Mark R. Lovell

Psychiatry

Research output: Contribution to journal › Review article › peer-review

29 Scopus citations

Abstract

Growing numbers of people throughout the United States (40% in 1998) are using various forms of alternative therapies. A MEDLINE literature search of journals from the past three decades and an Internet database query were performed to determine the types and frequency of alternative therapies used, with special attention given to the herbal medicines used in neuropsychiatric disorders. Clinical effects, mechanisms of action, interactions, and adverse reactions of the herbal treatments are detailed. Objective controlled trials will be needed to establish safety and efficacy of herbal supplements. Knowledge of the properties of these therapies can improve the care of neuropsychiatric patients.

Original language	English (US)
Pages (from-to)	177-192
Number of pages	16
Journal	Journal of Neuropsychiatry and Clinical Neurosciences
Volume	12
Issue number	2
DOIs	https://doi.org/10.1176/jnp.12.2.177
State	Published - 2000

ASJC Scopus subject areas

Clinical Neurology
Psychiatry and Mental health

Access to Document

10.1176/jnp.12.2.177

Fingerprint Dive into the research topics of 'The use of herbal alternative medicines in neuropsychiatry: A report of the ANPA Committee on Research'. Together they form a unique fingerprint.

Cite this

LaFrance, W. C., Lauterbach, E. C., Coffey, C. E., Salloway, S. P., Kaufer, D. I., Reeve, A., Royall, D. R., Aylward, E., Rummans, T. A., & Lovell, M. R. (2000). The use of herbal alternative medicines in neuropsychiatry: A report of the ANPA Committee on Research. Journal of Neuropsychiatry and Clinical Neurosciences, 12(2), 177-192. https://doi.org/10.1176/jnp.12.2.177

The use of herbal alternative medicines in neuropsychiatry : A report of the ANPA Committee on Research. / LaFrance, W. Curt; Lauterbach, Edward C.; Coffey, C. Edward; Salloway, Stephen P.; Kaufer, Daniel I.; Reeve, Alison; Royall, Donald R.; Aylward, Elizabeth; Rummans, Teresa A.; Lovell, Mark R.

In: Journal of Neuropsychiatry and Clinical Neurosciences, Vol. 12, No. 2, 2000, p. 177-192.

Research output: Contribution to journal › Review article › peer-review

LaFrance, W. Curt ; Lauterbach, Edward C. ; Coffey, C. Edward ; Salloway, Stephen P. ; Kaufer, Daniel I. ; Reeve, Alison ; Royall, Donald R. ; Aylward, Elizabeth ; Rummans, Teresa A. ; Lovell, Mark R. / The use of herbal alternative medicines in neuropsychiatry : A report of the ANPA Committee on Research. In: Journal of Neuropsychiatry and Clinical Neurosciences. 2000 ; Vol. 12, No. 2. pp. 177-192.

@article{498ae446e5704200a94064b8c4620703,

title = "The use of herbal alternative medicines in neuropsychiatry: A report of the ANPA Committee on Research",

abstract = "Growing numbers of people throughout the United States (40% in 1998) are using various forms of alternative therapies. A MEDLINE literature search of journals from the past three decades and an Internet database query were performed to determine the types and frequency of alternative therapies used, with special attention given to the herbal medicines used in neuropsychiatric disorders. Clinical effects, mechanisms of action, interactions, and adverse reactions of the herbal treatments are detailed. Objective controlled trials will be needed to establish safety and efficacy of herbal supplements. Knowledge of the properties of these therapies can improve the care of neuropsychiatric patients.",

author = "LaFrance, {W. Curt} and Lauterbach, {Edward C.} and Coffey, {C. Edward} and Salloway, {Stephen P.} and Kaufer, {Daniel I.} and Alison Reeve and Royall, {Donald R.} and Elizabeth Aylward and Rummans, {Teresa A.} and Lovell, {Mark R.}",

year = "2000",

doi = "10.1176/jnp.12.2.177",

language = "English (US)",

volume = "12",

pages = "177--192",

journal = "Journal of Neuropsychiatry and Clinical Neurosciences",

issn = "0895-0172",

publisher = "American Psychiatric Publishing Inc.",

number = "2",

}

TY - JOUR

T1 - The use of herbal alternative medicines in neuropsychiatry

T2 - A report of the ANPA Committee on Research

AU - LaFrance, W. Curt

AU - Lauterbach, Edward C.

AU - Coffey, C. Edward

AU - Salloway, Stephen P.

AU - Kaufer, Daniel I.

AU - Reeve, Alison

AU - Royall, Donald R.

AU - Aylward, Elizabeth

AU - Rummans, Teresa A.

AU - Lovell, Mark R.

PY - 2000

Y1 - 2000

N2 - Growing numbers of people throughout the United States (40% in 1998) are using various forms of alternative therapies. A MEDLINE literature search of journals from the past three decades and an Internet database query were performed to determine the types and frequency of alternative therapies used, with special attention given to the herbal medicines used in neuropsychiatric disorders. Clinical effects, mechanisms of action, interactions, and adverse reactions of the herbal treatments are detailed. Objective controlled trials will be needed to establish safety and efficacy of herbal supplements. Knowledge of the properties of these therapies can improve the care of neuropsychiatric patients.

AB - Growing numbers of people throughout the United States (40% in 1998) are using various forms of alternative therapies. A MEDLINE literature search of journals from the past three decades and an Internet database query were performed to determine the types and frequency of alternative therapies used, with special attention given to the herbal medicines used in neuropsychiatric disorders. Clinical effects, mechanisms of action, interactions, and adverse reactions of the herbal treatments are detailed. Objective controlled trials will be needed to establish safety and efficacy of herbal supplements. Knowledge of the properties of these therapies can improve the care of neuropsychiatric patients.

UR - http://www.scopus.com/inward/record.url?scp=0342657082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0342657082&partnerID=8YFLogxK

U2 - 10.1176/jnp.12.2.177

DO - 10.1176/jnp.12.2.177

M3 - Review article

C2 - 11001596

AN - SCOPUS:0342657082

VL - 12

SP - 177

EP - 192

JO - Journal of Neuropsychiatry and Clinical Neurosciences

JF - Journal of Neuropsychiatry and Clinical Neurosciences

SN - 0895-0172

IS - 2

ER -